U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955741) titled 'A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants' on April 25.

Brief Summary: The purpose of this study is to assess drug levels, tolerability and absolute biological availability of single subcutaneous dose of BMS-986446 in healthy participants

Study Start Date: May 06

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: BMS-986446 IV

Specified dose on specified days was administered intravenously (IV).

DRUG: BMS-986446 SC

Specified dose on specified days was administered subcutaneously (SC).

DRUG: Acetaminophen

Spec...